AbbVie Selects Durham for New $1.4 Billion Manufacturing Campus

Will create 734 jobs and is AbbVie’s largest-ever capital investment in a single campus

Durham, N.C. – Today, AbbVie (NYSE: ABBV) announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina. The state-of-the-art campus will support the production of AbbVie’s immunology, neuroscience and oncology medicines. Durham was selected based on the strength of its local workforce and its ability to support future expansion.

Will create 734 new jobs

Largest capital investment in AbbVie’s history for a single campus

Supporting production of medicines in immunology, neuroscience & oncology

Construction begins this year, with completion expected by 2028.

Current and future job openings will be posted at www.abbvie.com/manufacturing